Seroprevalence of HCV and its co-infection with HBV and HIV among liver disease patients of South Tamil Nadu

Table 7 Liver function test in HCV infected and co-infected patients (mean ± SD, n = 29)

Category	Liver function test
	Bilirubin (mg%)			SAP (KA units)	ALT (IU/L)	AST (IU/L)	GGT (IU/L)	Albumin (gms%)
	Total	Direct	Indirect
Control	0.5340 ± 0.219	0.210 ± 0.055	0.386 ± 0.015	73.227 ± 21.622	37.76 ± 9.35	24.77 ± 07.65	69.70 ± 11.03	2.78 ± 0.219
HCV positive patients	3.461 ± 0.874	0.643 ± 0.1736	0.936 ± 0.016	144.630 ± 12.976	42.1 ± 8.3	49.00 ± 10.1	98.446 ± 09.57	3.87 ± 0.24
P value	0	0	0	0.005	0	0	0	0
HCV and HBV coinfected patients	3.70 ± 0.96	1.59 ± 0.06	1.641 ± 0.052	140.887 ± 10.922	58.0 ± 03.16	40.412 ± 02.008	99.362 ± 06.150	3.14 ± 0.66
P value	0	0	0	0	0	0	0	0
HCV and HIV coinfected patients	2.920 ± 1.032	1.975 ± 0.941	1.997 ± 0.078	134.53 ± 10.651	56.78 ± 4.401	39.65 ± 2.24	97.60 ± 5.94	3.12 ± 0.97
P value	0	0.001	0.001	0	0.001	0.001	0	0
HCV, HBV and HIV coinfected patients	3.295 ± 1.424	3.202 ± 0.488	0.265 ± 0.052	141 ± 17.301	64.37 ± 4.01	42.87 ± 2.84	99.95 ± 03.039	3.14 ± 0.02
P value	0.009	0	0	0	0.005	0.006	0.003	0.004

HCV positive patients: P values are based on students t test; P < 0.05 significant.